Jonathan J Darrow
Biographic Data
| ID | 6074483 |
|---|---|
| NAME | Jonathan J Darrow |
| GIVEN NAMES | Jonathan J |
| FAMILY NAME | Darrow |
| SIGNATURE | DARROW J J |
| AFFILIATIONS | The authors are with the Program on Regulation, Therapeutics, and Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA. |
| ORCID | 0000-0002-7351-4243 |
| VERIFIED | No |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 1 |
| WORKS AS AUTHOR | 3 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2020 |
| LATEST PUBLICATION YEAR | 2023 |
| H-INDEX | 1 |
Securing the Trustworthiness of the FDA to Build Public Trust in Vaccines
The Covid‐19 pandemic highlighted the need to examine public trust in the U.S. Food and Drug Administration (FDA) vaccine approval process and the role of political influence in the FDA's decisions. Ensuring that the FDA is itself trustworthy is important for justifying public trust in its actions, like vaccine approvals, thereby promoting public health. We propose five conditions of trustworthiness that the FDA should meet when it reviews vaccin…
Government Patent Use to Promote Public Health in the United States
Government Patent Use to Promote Public Health in the United States: Overcoming Nonpatent Exclusivities Rebecca E. WolitzJD, PhD, Aaron S. KesselheimMD, JD, MPH, and Jonathan J. DarrowSJD, LLM, JD, MBA Affiliation Rebecca E. Wolitz is with the Moritz College of Law, The Ohio State University, Columbus. Jonathan J. Darrow and Aaron S. Kesselheim are with the Program on Regulation, Therapeutics, and Law, Department of Medicine, Brigham and Women’s …
Drug Shortages and the Defense Production Act
Drug Shortages and the Defense Production Act Brooke L. Raunig JD, RN, Aaron S. Kesselheim MD, JD, MPH, and Jonathan J. Darrow SJD, JD, MBA Affiliation The authors are with the Program on Regulation, Therapeutics, and Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.CopyRightCorrespondence should be sent to Brooke L. Raunig, Research Fellow, De…
Drug Shortages and the Defense Production Act
Drug Shortages and the Defense Production Act Brooke L. Raunig JD, RN, Aaron S. Kesselheim MD, JD, MPH, and Jonathan J. Darrow SJD, JD, MBA Affiliation The authors are with the Program on Regulation, Therapeutics, and Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.CopyRightCorrespondence should be sent to Brooke L. Raunig, Research Fellow, De…
Drug Shortages and the Defense Production Act
Drug Shortages and the Defense Production Act Brooke L. Raunig JD, RN, Aaron S. Kesselheim MD, JD, MPH, and Jonathan J. Darrow SJD, JD, MBA Affiliation The authors are with the Program on Regulation, Therapeutics, and Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.CopyRightCorrespondence should be sent to Brooke L. Raunig, Research Fellow, De…
Government Patent Use to Promote Public Health in the United States
Government Patent Use to Promote Public Health in the United States: Overcoming Nonpatent Exclusivities Rebecca E. WolitzJD, PhD, Aaron S. KesselheimMD, JD, MPH, and Jonathan J. DarrowSJD, LLM, JD, MBA Affiliation Rebecca E. Wolitz is with the Moritz College of Law, The Ohio State University, Columbus. Jonathan J. Darrow and Aaron S. Kesselheim are with the Program on Regulation, Therapeutics, and Law, Department of Medicine, Brigham and Women’s …
Securing the Trustworthiness of the FDA to Build Public Trust in Vaccines
The Covid‐19 pandemic highlighted the need to examine public trust in the U.S. Food and Drug Administration (FDA) vaccine approval process and the role of political influence in the FDA's decisions. Ensuring that the FDA is itself trustworthy is important for justifying public trust in its actions, like vaccine approvals, thereby promoting public health. We propose five conditions of trustworthiness that the FDA should meet when it reviews vaccin…
Medicine (3 works) · Family medicine (2 works) · Law (2 works) · Pharmaceutical Economics and Policy (2 works) · Political science (2 works) · Public health (2 works) · Agency (philosophy) (1 work) · Business (1 work) · Computer Science (1 work) · Consistency (knowledge bases) (1 work)